COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey.
COVID-19
health care
patient survey
systemic vasculitis
vaccination coverage
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
20
11
2022
accepted:
15
12
2022
entrez:
26
1
2023
pubmed:
27
1
2023
medline:
27
1
2023
Statut:
epublish
Résumé
To analyze the impact of the COVID-19 pandemic on medical care and vaccination acceptance of vasculitis patients in Germany. A web-based national survey was developed by rheumatology centers and vasculitis patient advocacy groups. The survey was distributed nationwide by mail and flyers and could be accessed via a QR-code or weblink from December 2021 to April 2022. Descriptive statistics [mean, median, standard derivation (SD), 25%, 75% quantile] were calculated. 95% confidence intervals were presented for responses that were directly related to the impact of COVID-19 on parameters associated with vasculitis patient care. The online survey was completed by 117 patients with small and large vessel vasculitis [granulomatosis with polyangiitis ( Vasculitis patients experienced changes in medical care during COVID-19 pandemic such as cancelation of prescheduled rheumatology appointments and modifications in therapeutic regimens. The overall acceptance rate for vaccination was comparatively high, particularly for vaccination against COVID-19.
Identifiants
pubmed: 36698843
doi: 10.3389/fmed.2022.1103694
pmc: PMC9868561
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1103694Informations de copyright
Copyright © 2023 Kernder, Filla, de Groot, Hellmich, Holle, Lamprecht, Moosig, Ruffer, Specker, Vordenbäumen, Schneider and Chehab.
Déclaration de conflit d'intérêts
KG was employed by Sana Klinikum Offenbach GmbH. NR was employed by Klinikum Bad Bramstedt GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Vaccine. 2018 Aug 6;36(32 Pt B):4875-4879
pubmed: 29980390
Am J Kidney Dis. 2020 Jan;75(1):124-137
pubmed: 31358311
J Rheumatol. 2021 Oct;48(10):1616-1622
pubmed: 34329183
Immun Inflamm Dis. 2022 Mar;10(3):e589
pubmed: 35099852
Medicine (Baltimore). 2021 Dec 23;100(51):e28305
pubmed: 34941119
Semin Arthritis Rheum. 2021 Aug;51(4):786-792
pubmed: 34148007
Kidney Int Rep. 2021 Nov;6(11):2903-2907
pubmed: 34426797
Vaccines (Basel). 2022 Feb 07;10(2):
pubmed: 35214709
RMD Open. 2021 Jan;7(1):
pubmed: 33402443
Lancet Rheumatol. 2021 Jun;3(6):e419-e426
pubmed: 33786454
N Engl J Med. 2014 Nov 6;371(19):1771-80
pubmed: 25372085
Turk J Med Sci. 2021 Apr 17;51(5):2243-2247
pubmed: 33862669
Lancet Rheumatol. 2021 Oct;3(10):e707-e714
pubmed: 34316727
Ann Rheum Dis. 2015 Jan;74(1):8-13
pubmed: 25261577
Ann Rheum Dis. 2020 Jun;79(6):840-842
pubmed: 32345619
Ann Rheum Dis. 2020 Jul;79(7):851-858
pubmed: 32503854
Intern Med J. 2021 Feb;51(2):199-205
pubmed: 33631862
J Med Internet Res. 2004 Sep 29;6(3):e34
pubmed: 15471760
Autoimmun Rev. 2021 Dec;20(12):102986
pubmed: 34718165
Ann Rheum Dis. 2021 Apr;80(4):e61
pubmed: 32475833
Z Rheumatol. 2021 Dec;80(Suppl 2):33-48
pubmed: 34491403
Z Rheumatol. 2020 May;79(4):385-388
pubmed: 32342184
Ann Rheum Dis. 2016 Sep;75(9):1583-94
pubmed: 27338776
J Rheumatol. 2022 Jan;49(1):118-119
pubmed: 34654731
Rheumatol Int. 2021 Nov;41(11):1941-1947
pubmed: 34427760
MMW Fortschr Med. 2021 Jan;163(1):18-19
pubmed: 33464492
Ann Rheum Dis. 2021 Apr;80(4):518-526
pubmed: 33158877
Ann Rheum Dis. 2015 Jun;74(6):1178-82
pubmed: 25739829
Ann Rheum Dis. 2021 Jul;80(7):930-942
pubmed: 33504483
N Engl J Med. 2010 Jul 15;363(3):221-32
pubmed: 20647199
Rheumatology (Oxford). 2020 Sep 1;59(9):2308-2315
pubmed: 31846030